These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 25897293)

  • 1. The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.
    Xie Y; Shen S; Zhang J; Wang W; Zheng J
    Int J Med Sci; 2015; 12(4):322-8. PubMed ID: 25897293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.
    Shen S; Zhang J; Wang W; Zheng J; Xie Y
    J Transl Med; 2016 Jul; 14(1):228. PubMed ID: 27473326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of cell salvage in pediatric surgery.
    Samnaliev M; Tran CM; Sloan SR; Gasior I; Lightdale JR; Brustowicz RM
    Paediatr Anaesth; 2013 Nov; 23(11):1027-34. PubMed ID: 23952976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
    Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, efficacy, and cost-effectiveness of intraoperative blood salvage in OPCABG with different amount of bleeding: a single-center, retrospective study.
    Wang H; Zheng W; Fang W; Meng G; Zhang L; Zhou Y; Gu E; Liu X
    J Cardiothorac Surg; 2018 Oct; 13(1):109. PubMed ID: 30333028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study.
    Vonk AB; Meesters MI; Garnier RP; Romijn JW; van Barneveld LJ; Heymans MW; Jansen EK; Boer C
    Transfusion; 2013 Nov; 53(11):2782-9. PubMed ID: 23445352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep device.
    Boyle G; Kuffel A; Parmar K; Gibson K; Smith M; Grehan A; Hunt BJ; Chambers DJ
    Perfusion; 2019 Jan; 34(1):76-83. PubMed ID: 30067140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of cell saver system in cardiac surgery with cardiopulmonary bypass.
    Almeida RM; Leitão L
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):76-82. PubMed ID: 23739936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
    So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
    Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems.
    Scrascia G; Rotunno C; Nanna D; Rociola R; Guida P; Rubino G; de Luca Tupputi Schinosa L; Paparella D
    Perfusion; 2012 Jul; 27(4):270-7. PubMed ID: 22440640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison.
    Weltert L; Nardella S; Rondinelli MB; Pierelli L; De Paulis R
    Transfusion; 2013 Apr; 53(4):790-7. PubMed ID: 22882381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial.
    Karkouti K; von Heymann C; Jespersen CM; Korte W; Levy JH; Ranucci M; Sellke FW; Song HK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):927-39. PubMed ID: 23820174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of cell salvage in routine cardiac surgery is ineffective and not cost-effective and should be reserved for selected cases.
    Attaran S; McIlroy D; Fabri BM; Pullan MD
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):824-6. PubMed ID: 21297148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin Complex Concentrate vs Plasma for Post-Cardiopulmonary Bypass Coagulopathy and Bleeding: A Randomized Clinical Trial.
    Smith MM; Schroeder DR; Nelson JA; Mauermann WJ; Welsby IJ; Pochettino A; Montonye BL; Assawakawintip C; Nuttall GA
    JAMA Surg; 2022 Sep; 157(9):757-764. PubMed ID: 35767271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardiopulmonary bypass circuit reduction and residual volume salvage on allogeneic transfusion requirements in infants undergoing cardiac surgery.
    Golab HD; Takkenberg JJ; van Gerner-Weelink GL; Wijers MJ; Scohy TV; de Jong PL; Bogers AJ
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):335-9. PubMed ID: 17669859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass.
    Kindo M; Hoang Minh T; Gerelli S; Perrier S; Meyer N; Schaeffer M; Bentz J; Announe T; Mommerot A; Collange O; Pottecher J; Cristinar M; Thiranos JC; Gros H; Mertes PM; Billaud P; Mazzucotelli JP
    Thromb Res; 2014 Aug; 134(2):360-8. PubMed ID: 24857189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between intraoperative cell salvage and red blood cell transfusion in cardiac surgery - an observational study in a patient blood management centre.
    Neef V; Vo L; Herrmann E; Triphaus C; Judd L; Winter A; Zacharowski K; Choorapoikayil S; Meybohm P
    Anaesthesiol Intensive Ther; 2021; 53(1):1-9. PubMed ID: 33625822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.
    Diprose P; Herbertson MJ; O'Shaughnessy D; Deakin CD; Gill RS
    Br J Anaesth; 2005 Mar; 94(3):271-8. PubMed ID: 15591329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified laparoscopic splenectomy and azygoportal disconnection combined with cell salvage is feasible and might reduce the need for blood transfusion.
    Jiang GQ; Bai DS; Chen P; Qian JJ; Jin SJ; Yao J; Wang XD
    World J Gastroenterol; 2014 Dec; 20(48):18420-6. PubMed ID: 25561811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study.
    Karkouti K; Callum J; Crowther MA; McCluskey SA; Pendergrast J; Tait G; Yau TM; Beattie WS
    Anesth Analg; 2013 Jul; 117(1):14-22. PubMed ID: 23687229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.